Inventor · disambiguated record
Peter L. Sazani
Also filed as: SAZANI PETER · SAZANI PETER L
9 granted patents·27 pending applications·388 citations·filing 2006–2024
92Inventor score
Files withSAREPTA THERAPEUTICS INC13ROCHE INNOVATION CT COPENHAGEN AS10SAZANI PETER L5SANTARIS PHARMA AS3AVI BIOPHARMA INC1
Top patents by PatentIndex Score
36 records- 0198US9447417B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·61 cites·4 claims
- 0298US9447416B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·40 cites·8 claims
- 0398US9434948B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 6, 2016·52 cites·8 claims
- 0498US9234198B1Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Jan 12, 2016·35 cites·8 claims
- 0598US8865883B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2013·Granted Oct 21, 2014·95 cites·21 claims
- 0697US9453225B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 27, 2016·23 cites·4 claims
- 0796US8871918B2Multiple exon skipping compositions for DMDSAZANI PETER·Filed 2009·Granted Oct 28, 2014·69 cites·38 claims
- 0894US7884194B2Soluble HER2 and HER3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of diseaseAVI BIOPHARMA INC·Filed 2008·Granted Feb 8, 2011·13 cites·4 claims
- 0993US2025154507A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1076US2021180060A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1176US2020283776A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 1273US2021363222A1Soluble TNF Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2020·Application pending·0 cites
- 1373US2019309047A1Soluble TNF Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 1472US2019127738A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1571US2019284556A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1669US2015152415A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1768US2017198024A1Soluble TNF Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
- 1868US2018066259A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1966US2017292125A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2066US2019017052A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 2164US2018051290A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
- 2264US2013123479A1Soluble TNF Receptors and Their Use in Treatment of DiseaseSAZANI PETER L·Filed 2012·Application pending·0 cites
- 2362US2014057968A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseSAZANI PETER L·Filed 2013·Application pending·0 cites
- 2462US2009264353A1Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of DiseaseSANTARIS PHARMA AS·Filed 2007·Application pending·0 cites
- 2562US2017191067A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
- 2662US2007105807A1Splice switch oligomers for TNF superfamily receptors and their use in treatment of diseaseSAZANI PETER L·Filed 2006·Application pending·0 cites
- 2761US2015166634A1Soluble TNF Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 2859US2011105740A1Soluble tnf receptors and their use in treatment of diseaseSANTARIS PHARMA AS A DENMARK CORP·Filed 2010·Application pending·0 cites
- 2959US2014357849A1Splice switching oligomers for tnf superfamily receptors and their use in treatment of diseaseSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 3056US2011237521A1Splice switching oligomers for tnf superfamily receptors and their use in treatment of diseaseSAZANI PETER L·Filed 2010·Application pending·0 cites
- 3155US7785834B2Soluble TNF receptors and their use in treatment of diseaseERCOLE BIOTECH INC·Filed 2007·Granted Aug 31, 2010·0 cites·6 claims
- 3251US2017015697A1Splice switching oligomers for tnf superfamily receptors and their use in treatment of diseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 3349US2019359986A1Splice switching oligomers for tnf superfamily receptors and their use in treatment of diseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 3442US2012040917A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseOERUM HENRIK·Filed 2010·Application pending·0 cites
- 3540US2012142759A1Soluble thf receptors and their use in treatment of diseaseSAZANI PETER L·Filed 2007·Application pending·0 cites
- 3638US2015252371A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseSANTARIS PHARMA AS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →